Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HIV-1 Infection”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Large-scale testing (Phase 3)Study completedNCT00552682
What this trial is testing

Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+

Who this might be right for
FibromyalgiaHIV-1 Infection
Germans Trias i Pujol Hospital 10
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Early research (Phase 1)Study completedNCT00857311
What this trial is testing

MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 17
Not applicableStudy completedNCT04133012
What this trial is testing

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 20
Not applicableEnrolling By InvitationNCT02699736
What this trial is testing

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Who this might be right for
HIVHepatitis BHepatitis C+10 more
Rigshospitalet, Denmark 23,000
Testing effectiveness (Phase 2)Study completedNCT02578706
What this trial is testing

Targeting Platelets in Chronic HIV Infection

Who this might be right for
HIV-1 Infection
Icahn School of Medicine at Mount Sinai 27
Not applicableNot Yet RecruitingNCT05222945
What this trial is testing

Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 34
Very early researchStudy completedNCT04820933
What this trial is testing

Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV

Who this might be right for
HIV I InfectionCardiovascular Risk FactorLipid Metabolism Disorders
University of Texas Southwestern Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT00983853
What this trial is testing

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Who this might be right for
Hepatitis CHIV Infections
Vertex Pharmaceuticals Incorporated 62
Not applicableStudy completedNCT00087945
What this trial is testing

Blood Levels of Abacavir in HIV Infected Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT01479868
What this trial is testing

Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Who this might be right for
Hepatitis C Virus Genotype-1
Janssen R&D Ireland 109
Not applicableStudy completedNCT01423643
What this trial is testing

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

Who this might be right for
HIV InfectionHepatitis C
Johns Hopkins University 1,250
Large-scale testing (Phase 3)Study completedNCT01453192
What this trial is testing

Renal Transplantation and Raltegravir in HIV-Infected Patients

Who this might be right for
HIV-1 InfectionChronic Renal Insufficiency
ANRS, Emerging Infectious Diseases 27
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Testing effectiveness (Phase 2)Ended earlyNCT04840199
What this trial is testing

Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Who this might be right for
HIV InfectionsCytomegalovirusCMV
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT04120415
What this trial is testing

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 2
Not applicableStudy completedNCT01876862
What this trial is testing

Towards HIV Functional Cure

Who this might be right for
Chronic HIV-1 Infection
Objectif Recherche Vaccins SIDA 15
Large-scale testing (Phase 3)Study completedNCT01513941
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Chronic Hepatitis C
Janssen-Cilag International NV 163
Next Page